Drug search by name

Oxaliplatin Concentrate Injection and Pulmonary toxicity

Result of checking the interaction of drug Oxaliplatin Concentrate Injection and disease Pulmonary toxicity for safety when used together.

Check result:

Oxaliplatin Concentrate Injection <> Pulmonary toxicity

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Oxaliplatin has been associated with pulmonary fibrosis (<1% of study patients), which may be fatal. Caution should be exercised when administering oxaliplatin in patients with compromised pulmonary function. Patients should be instructed to immediately report symptoms of unexplained respiratory symptoms such as non-productive cough, dyspnea, crackles, or radiological pulmonary infiltrates. Close clinical monitoring of pulmonary function is recommended and oxaliplatin should be discontinued until further pulmonary investigation excludes interstitial lung disease or pulmonary fibrosis.

Oxaliplatin Concentrate Injection

Generic Name: oxaliplatin

Brand Name: Eloxatin

Synonyms: Oxaliplatin

What is Oxaliplatin Concentrate Injection?